Metastatic extraskeletal myxoid chondrosarcoma. Successful therapy with interferon alfa-2b.
A patient with pulmonary metastatic extraskeletal myxoid chondrosarcoma (EMC), of unknown cause, responded dramatically to 16 months of therapy with interferon alfa-2b. This is the first report of a significant response of a patient with EMC to this novel treatment approach.